SA Pharmacy, SA Health, Adelaide, South Australia, Australia.
College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
PLoS One. 2022 May 4;17(5):e0267969. doi: 10.1371/journal.pone.0267969. eCollection 2022.
Admission to hospital introduces risks for people with Parkinson's disease in maintaining continuity of their highly individualized medication regimens, which increases their risk of medication errors. This is of particular concern as omitted medications and irregular dosing can cause an immediate increase in an individual's symptoms as well as other adverse outcomes such as swallowing difficulties, aspiration pneumonia, frozen gait and even potentially fatal neuroleptic malignant type syndrome.
To determine the occurrence and identify factors that contribute to Parkinson's medication errors in Australian hospitals.
A retrospective discharge diagnosis code search identified all admissions for people with Parkinson's disease to three tertiary metropolitan hospitals in South Australia, Australia over a 3-year period. Of the 405 case notes reviewed 351 admissions met our inclusion criteria.
Medication prescribing (30.5%) and administration (85%) errors during admission were extremely common, with the most frequent errors related to administration of levodopa preparations (83%). A higher levodopa equivalent dosage, patients with a modified swallowing status or nil by mouth order during admission, and patients who did not have a pharmacist led medication history within 24 hours of admission had significantly higher rates of medication errors.
This study identified 3 major independent factors that increased the risk of errors during medication management for people with Parkinson's disease during hospitalization. Thus, targeting these areas for preventative interventions have the greatest chance of producing a clinically meaningful impact on the number of hospital medication errors occurring in the Parkinson's population.
住院会给帕金森病患者带来风险,使他们难以维持高度个体化的药物治疗方案的连续性,从而增加药物错误的风险。这尤其令人担忧,因为漏服药物和不规则给药会导致个体症状立即加重,以及其他不良后果,如吞咽困难、吸入性肺炎、冻结步态,甚至可能致命的神经阻滞剂恶性综合征。
确定澳大利亚医院帕金森病药物错误的发生情况,并确定导致药物错误的因素。
通过回顾性出院诊断代码搜索,确定了在澳大利亚南澳大利亚州的三家三级大都市医院住院的所有帕金森病患者,时间跨度为 3 年。在审查的 405 份病历中,有 351 份符合我们的纳入标准。
住院期间药物处方(30.5%)和给药(85%)错误极为常见,最常见的错误与左旋多巴制剂的给药有关(83%)。左旋多巴等效剂量较高、入院时吞咽功能改变或禁食、入院 24 小时内没有药剂师主导的药物史的患者,药物错误的发生率显著更高。
本研究确定了 3 个主要的独立因素,这些因素增加了住院期间帕金森病患者药物管理中出现错误的风险。因此,针对这些领域进行预防干预,最有可能对帕金森病患者发生的医院药物错误数量产生有临床意义的影响。